Pacific Biosciences Of California (PACB) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Pacific Biosciences Of California (PACB) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 16.91% |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | 18.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.23% |
| Mar 31, 2026 | 98.03% |
| Dec 31, 2025 | 15.90% |
| Sep 30, 2025 | -856.38% |
| Jun 30, 2025 | -298.18% |
| Mar 31, 2025 | -8,134.41% |
| Dec 31, 2024 | 9.83% |
| Sep 30, 2024 | 22.32% |
| Jun 30, 2024 | 68.84% |
| Mar 31, 2024 | 88.19% |
| Dec 31, 2023 | 49.72% |
| Sep 30, 2023 | 55.47% |
| Jun 30, 2023 | -11.51% |
| Mar 31, 2023 | -19.88% |
| Dec 31, 2022 | -409.39% |
| Jun 30, 2022 | -2,387.42% |
| Mar 31, 2022 | -169.10% |
| Jun 30, 2021 | -81.92% |
| Mar 31, 2021 | 77.82% |
| Sep 30, 2020 | 95.56% |